已收盘 09-22 16:00:00 美东时间
0.000
0.00%
Magellan Financial Group Ltd ( ($AU:MFG) ) has issued an update. Magellan Finan...
07-01 16:07
BUZZ-Australia's Magellan surges as Barrenjoey acquisition completes ** Magellan Financial MFG.AX shares jump nearly 14% to A$11.005, their highest level since March 10, while the broader benchmark .AXJO trades down 0.7% ** Stock among top gainers on AXJO, headed for strongest trading session since
07-01 13:54
Gain Therapeutics' GT-02287 has received FDA IND authorization, enabling Phase 2 clinical development in the U.S. for Parkinson's disease. Positive Phase 1 results showed target engagement, safety, and tolerability, with anecdotal improvements in symptoms. GT-02287, developed using Gain's Magellan AI platform, is the first allosteric modulator to achieve IND clearance. Phase 2 is expected to begin in 3Q26, involving sites in the U.S., Australia, ...
06-29 20:05
Magellan Financial Group Ltd ( ($AU:MFG) ) has shared an announcement. Magellan...
06-22 11:12
Magellanic Cloud Ltd. ( ($IN:MCLOUD) ) just unveiled an update. Magellanic Clou...
06-20 16:23
Magellan Aerospace (MAL:CA) received approval for its renewal of a normal course issuer bid, allowing the company to repurchase up to ~2.85M common shares over the next 12 months. The program will run...
06-11 20:01
Gain Therapeutics, Inc. announced that its President and CEO, Gene Mack, will participate in a virtual fireside chat and one-on-one meetings at the H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit on June 15-16, 2026. The fireside chat replay will be available from June 15, 2026, at 7:00 a.m. EDT. Gain Therapeutics is a clinical-stage biotechnology company focused on developing next-generation allosteric therapies, with its lead candid...
06-10 11:00
On Tuesday, Academy Sports (NASDAQ:ASO) discussed first-quarter financial resul...
06-09 23:16
Magellan Copper and Gold Q1 FY26 net loss narrows to $168,953 Magellan Copper and Gold posted a net loss of $168,953 for quarter ended March 31, 2026, narrowing from $184,140 a year earlier. Operating loss widened to $113,041 from $58,036, with general and administrative expenses rising to $113,041
05-15 18:20
Arteris (NASDAQ:AIP) released first-quarter financial results and hosted an ear...
05-13 05:21